|Description:||1. Carlinoside could be a worthy choice to intervene hyperbilirubinemia due to liver dysfunction. |
2. Carlinoside upregulates Nrf2 gene expression, increases its nuclear translocation and stimulates UGT1A1 promoter activity.
|Source:||The herbs of Lespedeza bicolor Turcz.|
|Solvent:||DMSO, Pyridine, Methanol, Ethanol, etc.|
|Storage:||Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: email@example.com
|After receiving:||The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.|
|1 mg||5 mg||10 mg||20 mg||25 mg|
|1 mM||1.7227 mL||8.6133 mL||17.2265 mL||34.4531 mL||43.0663 mL|
|5 mM||0.3445 mL||1.7227 mL||3.4453 mL||6.8906 mL||8.6133 mL|
|10 mM||0.1723 mL||0.8613 mL||1.7227 mL||3.4453 mL||4.3066 mL|
|50 mM||0.0345 mL||0.1723 mL||0.3445 mL||0.6891 mL||0.8613 mL|
|100 mM||0.0172 mL||0.0861 mL||0.1723 mL||0.3445 mL||0.4307 mL|
Biochem Pharmacol. 2011 Nov 1;82(9):1186-97.
|Carlinoside reduces hepatic bilirubin accumulation by stimulating bilirubin-UGT activity through Nrf2 gene expression.[Pubmed: 21801714 ]|
|We demonstrated that suppression of UGT1A1 activity in rat liver increased serum bilirubin level which could be reversed by Carlinoside (Cln), a flavone glycoside. Although Carlinoside is a flavone compound, it escaped self-glucuronidation in the intestine and readily absorbed. Kinetic study of microsomal UGT1A1 from HepG2 cells suggested that Carlinoside enhanced enzyme activity by increasing V(max) without altering K(m). This altered V(max) was found to be due to UGT1A1 overexpression by Carlinoside which was observed in both HepG2 and rat primary hepatocytes. Since Nrf2 is the transcription factor of UGT1A1, we examined whether Cln effect on UGT1A1 overexpression is mediated through Nrf2. In Nrf2 knock-out cells, Carlinoside could not elevate UGT1A1 activity indicating Nrf2 to be its target. Carlinoside significantly increased Nrf2 gene expression in HepG2 cells which was subsequently localized in nuclear region. Results from ChIP assay showed that Carlinoside markedly augmented Nrf2 binding to UGT1A1 promoter that consequently enhanced reporter activity. Our findings therefore show that Carlinoside upregulated Nrf2 gene expression, increased its nuclear translocation and stimulated UGT1A1 promoter activity. Total outcome of these events brought about a significant increase of bilirubin glucuronidation. Carlinoside therefore could be a worthy choice to intervene hyperbilirubinemia due to liver dysfunction.|
J Ethnopharmacol. 2008 Jan 17;115(2):320-2.
|Compounds from Vitex polygama active against kidney diseases.[Pubmed: 17981413]|
|The yielded fraction was subsequently submitted to several chromatographic procedures to lead to the isolation of O-glycosidicflavones orientin and isoorientin as well as C-glycosylflavones schaftoside and Carlinoside along with their isomers, known as potent anti-inflammatory, antinociceptive and antioxidant agents, then identified as the active constituents, justifying the folk use of the plant to combat and prevent kidney stone and inflammation.|